IVP Ltd Q4 FY26: Stellar Margin Expansion Drives 131% Profit Surge

The quarter's standout feature was the company's dramatic margin expansion across all profitability metrics. Operating margins (excluding other income) reached a record 8.33%, substantially higher than the 5.20% recorded in the year-ago quarter. This 313 basis points improvement reflects enhanced operational efficiency and better cost management in the commodity chemicals business. The company's diversified product portfolio—spanning vanaspati, vegetable oils, plasticisers, spark plugs, and foundry chemicals—appears to be delivering improved pricing power and operational leverage.

Revenue for Q4 FY26 stood at ₹164.44 crores, representing healthy growth of 10.10% year-on-year from ₹149.36 crores and sequential expansion of 13.43% from ₹144.97 crores in Q3 FY26. The consistent top-line momentum over the past three quarters—with revenues climbing from ₹138.19 crores in Q1 FY26—demonstrates improving demand conditions and effective market penetration strategies. For the full year FY26, the company generated revenues of ₹594.55 crores across the first three quarters reported.

Financial Performance: Profitability Transformation Underway

The March 2026 quarter marks a pivotal inflection point in IVP's profitability trajectory. Operating profit (PBDIT excluding other income) surged to ₹13.70 crores—the highest quarterly figure in the company's recent history—compared to ₹7.77 crores in Q4 FY25 and ₹8.65 crores in the previous quarter. This 76.45% year-on-year expansion in absolute operating profit demonstrates the company's success in translating revenue growth into bottom-line performance through improved operational efficiency.

The profit before tax (PBT) reached ₹11.96 crores, more than doubling from ₹5.15 crores in the year-ago period, representing growth of 132.23%. After accounting for tax expenses of ₹3.10 crores at an effective rate of 25.92%, the company delivered net profit of ₹8.86 crores. The earnings per share (EPS) for the quarter stood at ₹8.58, the highest quarterly EPS recorded by the company in recent periods.

Interest expenses declined to ₹1.37 crores in Q4 FY26 from ₹2.10 crores in Q4 FY25, reflecting a 34.76% reduction that contributed significantly to the improved profitability. The operating profit to interest coverage ratio reached an impressive 10.00 times in the quarter—the highest level recorded—indicating substantially improved debt servicing capability and financial flexibility. Depreciation remained stable at ₹1.49 crores, marginally higher than ₹1.46 crores in the year-ago quarter.

Employee costs rose modestly to ₹6.12 crores from ₹5.17 crores year-on-year, representing an 18.38% increase that was well below the revenue growth rate of 10.10%. This suggests improving employee productivity and operating leverage. Other income contributed ₹1.12 crores to the quarter's performance, compared to ₹0.94 crores in Q4 FY25, though the company's core operating performance remains the primary driver of profitability.

Operational Excellence: Margin Expansion Takes Centre Stage

The most compelling aspect of IVP's Q4 FY26 performance is the dramatic margin expansion across all profitability levels. The operating margin (excluding other income) of 8.33% represents not only a 313 basis points improvement year-on-year but also marks the highest quarterly margin achieved by the company in recent history. This compares favourably to margins of 5.97% in Q3 FY26, 5.51% in Q2 FY26, and just 3.08% in Q1 FY26, demonstrating consistent sequential improvement throughout FY26.

The PAT margin expansion story is equally impressive. At 5.39% in Q4 FY26, the net profit margin has expanded by 283 basis points from 2.56% in Q4 FY25 and represents a near-doubling from the 2.72% margin in Q2 FY26. This margin progression—from 0.86% in Q1 FY26 to 2.72% in Q2, 3.19% in Q3, and finally 5.39% in Q4—illustrates a clear positive trajectory in the company's ability to convert revenue into profit.

From a return profile perspective, IVP's average return on equity (ROE) stands at 13.98%, which whilst moderate, represents a significant improvement from historical levels. The company's average return on capital employed (ROCE) of 10.53% over the longer term reflects the capital-intensive nature of the commodity chemicals business. However, the latest ROCE of 7.91% suggests recent capital deployment is still in the process of generating optimal returns, though the improving profitability trend indicates this metric should strengthen in coming quarters.

The company's balance sheet reveals a debt-free status with zero long-term debt as of March 2025, though working capital financing remains a component of the capital structure. Current liabilities stood at ₹206.39 crores against current assets of ₹273.22 crores, resulting in a healthy current ratio. Trade payables of ₹94.11 crores and other current liabilities of ₹7.06 crores are comfortably covered by the company's liquid resources. Fixed assets totalled ₹70.60 crores, with shareholder funds of ₹139.33 crores providing a stable equity base.

Industry Context: Navigating Commodity Chemicals Volatility

The commodity chemicals sector is characteristically volatile, with profitability heavily influenced by raw material costs, global supply-demand dynamics, and currency fluctuations. IVP's diversified product portfolio—encompassing vanaspati and vegetable oils (consumer-facing), plasticisers (industrial chemicals), spark plugs (automotive components), and foundry chemicals (industrial inputs)—provides some insulation against sector-specific headwinds, though it also exposes the company to multiple end-market cyclicalities.

The company's performance over the past year must be viewed against the backdrop of a challenging FY25, where full-year revenues declined 1.5% to ₹538.00 crores from ₹546.00 crores in FY24. This contraction followed a more severe 17.3% decline in FY24 from ₹660.00 crores in FY23. The recent quarterly momentum in FY26 therefore represents a potential turning point after two consecutive years of top-line pressure, though sustainability of this recovery remains to be demonstrated across a full fiscal year.

IVP's long-term growth profile shows impressive resilience. The company has delivered 5-year sales growth of 20.51% annually and even more impressive 5-year EBIT growth of 46.39% per annum. This suggests the business possesses underlying structural growth drivers and improving operational efficiency over the longer term, despite near-term cyclical challenges. The company's 93-year operating history since incorporation in 1929 provides institutional knowledge and established market positions across its diverse product lines.

Peer Comparison: Valuation Discount Despite Stronger Fundamentals

IVP's valuation metrics present an interesting contrast to its commodity chemicals peer group. Trading at a price-to-earnings ratio of 11.81x (based on trailing twelve months), the company sits at a significant discount to the peer group average of approximately 212x. However, this comparison is distorted by several loss-making peers with negative or extremely high P/E ratios. More meaningfully, IVP's P/E multiple is closely aligned with Kesar Petroproducts' 12.75x, suggesting similar market expectations for near-term growth.

From a profitability standpoint, IVP's average ROE of 13.98% significantly outpaces the peer group, where most companies report negligible or zero returns on equity. This superior return profile reflects IVP's established market positions and improving operational efficiency. The company's price-to-book ratio of 1.15x sits in the middle of the peer range (0.23x to 1.68x), suggesting the market values IVP's equity at a modest premium to book value—appropriate given the positive ROE generation.

IVP's debt-to-equity ratio of 0.69 (on an average basis) indicates moderate financial leverage, lower than some peers but higher than the debt-free status shown in the latest balance sheet. This suggests the company utilises working capital financing but maintains conservative long-term leverage. The dividend yield of 0.62% (based on the latest ₹1 per share dividend paid in July 2025) provides modest income, though the 8.41% dividend payout ratio indicates the company retains most earnings for reinvestment in the business.

Valuation Analysis: Attractive Entry Point at Current Levels

At the current market price of ₹179.00, IVP trades at a P/E ratio of 11.81x, representing a 9.2% discount to the commodity chemicals industry average P/E of 13x. This discount appears unjustified given the company's superior ROE profile and recent momentum in profitability. The price-to-book ratio of 1.15x suggests the market values the company's equity at just 15% above book value, despite the business generating returns on equity of approximately 14%—a spread that typically warrants a higher valuation multiple.

The enterprise value metrics provide additional perspective on valuation attractiveness. With an EV/EBITDA multiple of 9.21x, IVP trades at the lower end of historical valuations for profitable chemical companies. The EV/Sales ratio of 0.46x reflects the commodity nature of the business, where revenue multiples remain compressed. However, the improving margin profile suggests the company is transitioning towards a higher-quality earnings stream that could support multiple expansion.

The PEG ratio of 0.82 (price-to-earnings growth ratio) suggests the stock may be undervalued relative to its growth potential, as PEG ratios below 1.0 typically indicate attractive valuations for growth-oriented investors. However, this metric must be interpreted cautiously given the company's historical revenue volatility and the need to demonstrate sustainable growth beyond the recent quarterly momentum.

IVP's valuation grade has fluctuated between "Attractive" and "Fair" over the past year, with the current classification as "Attractive" since February 2024. The stock currently trades 13.55% below its 52-week high of ₹207.05 but 60.97% above its 52-week low of ₹111.20, suggesting the recent rally has been substantial but the stock remains below previous peak levels. At ₹179.00, the current price represents a potential entry point for investors seeking exposure to a turnaround story in the commodity chemicals space, though the micro-cap nature brings inherent liquidity and volatility risks.

Shareholding: Stable Promoter Base with Minimal Institutional Interest

IVP's shareholding structure reflects the characteristics of a closely-held, family-controlled business with minimal institutional participation. Promoter holding has remained rock-steady at 71.32% across the past five quarters (March 2025 through March 2026), with zero sequential changes in any quarter. The promoter group comprises entities affiliated with the Allana family, with Allana Exports Private Limited holding the largest stake at 34.31%, followed by Allana Cold Storage Private Limited (8.63%) and Anjaneya Cold Storage Private Limited (6.42%).

The complete absence of foreign institutional investor (FII) holdings and mutual fund participation highlights the stock's limited appeal to institutional investors, likely due to its micro-cap status, limited liquidity, and relatively low public float. Insurance company holdings are also zero, whilst other domestic institutional investors (DII) hold a negligible 0.02% stake. The non-institutional shareholding of 28.66%—comprising retail investors and non-institutional entities—has also remained unchanged throughout the period.

Positively, there is zero promoter pledging, indicating the controlling shareholders have not leveraged their holdings for financing purposes. This provides comfort regarding management's confidence in the business and eliminates concerns about forced selling in adverse market conditions. The stable shareholding pattern suggests an absence of aggressive buying or selling by any category, though the lack of institutional interest means the stock lacks the research coverage and liquidity that typically accompanies institutional ownership.

Stock Performance: Recent Surge Reverses Long-Term Underperformance

IVP's stock price performance presents a tale of two timeframes: impressive short-term momentum contrasted with extended long-term underperformance. The stock has delivered a remarkable 25.61% return over the past month, vastly outpacing the Sensex's 3.67% decline during the same period, resulting in an alpha of 29.28 percentage points. This surge accelerated in recent days, with the stock gaining 8.81% over the past week (versus Sensex +0.53%) and 11.88% on the day following the Q4 results announcement.

The three-month performance of +30.32% (alpha: +38.99%) and six-month return of +10.56% (alpha: +21.82%) demonstrate sustained positive momentum building through the latter part of FY26. Year-to-date, the stock has gained 23.15%, significantly outperforming the Sensex's 11.25% decline. However, the one-year return of just 0.79% reveals the stock spent much of the previous year in consolidation or decline before the recent breakout.

The longer-term performance picture is considerably less favourable. Over three years, IVP has delivered returns of just 3.11% compared to the Sensex's 22.06% gain, resulting in negative alpha of 18.95 percentage points. The five-year return of 44.06% underperforms the Sensex's 49.65% gain by 5.59 percentage points. This extended underperformance reflects the challenges faced by the company during FY24 and FY25, when revenues contracted and profitability came under pressure.

From a technical perspective, the stock currently trades above all major moving averages—5-day (₹159.74), 20-day (₹153.15), 50-day (₹139.49), 100-day (₹142.06), and 200-day (₹156.59)—a bullish configuration suggesting positive momentum. However, the overall technical trend is classified as "Mildly Bearish" as of May 18, 2026, with mixed signals from various indicators. The stock's high beta of 1.50 indicates significantly higher volatility than the broader market, with annualised volatility of 46.07% placing it in the "High Risk Medium Return" category.

Investment Thesis: Turnaround Story with Execution Risks

IVP's investment case centres on a potential operational turnaround evidenced by the dramatic margin expansion in Q4 FY26. The company has demonstrated its ability to improve profitability significantly—with operating margins more than doubling from 3.08% in Q1 FY26 to 8.33% in Q4 FY26—suggesting structural improvements in cost management and operational efficiency. The debt-free balance sheet provides financial flexibility, whilst the stable promoter holding of 71.32% with zero pledging indicates management confidence and alignment with minority shareholders.

The valuation appears attractive at a P/E of 11.81x, trading at a discount to the industry average despite superior return on equity. The PEG ratio of 0.82 suggests the stock may be undervalued relative to growth potential, though this must be balanced against the need to demonstrate sustained growth beyond a single strong quarter. The company's 5-year EBIT growth of 46.39% annually demonstrates the business's capacity for profit expansion when operating conditions align favourably.

However, significant risks temper the bullish case. The company's micro-cap status (₹184.84 crores market capitalisation) brings inherent liquidity constraints and volatility, with high beta of 1.50 and annualised volatility of 46.07%. The complete absence of institutional ownership—zero FII, mutual fund, and insurance holdings—reflects limited analyst coverage and market confidence. The business operates in cyclical commodity chemicals markets with limited pricing power, as evidenced by the revenue contractions in FY24 and FY25.

Outlook: What to Watch in Coming Quarters

The sustainability of Q4 FY26's margin expansion will be the critical factor determining whether IVP's recent performance represents a genuine turnaround or a temporary aberration. Investors should monitor whether operating margins can be maintained above 7-8% in coming quarters, as consistent margin performance would validate the structural nature of recent improvements. Revenue growth momentum is equally important—the company must demonstrate its ability to grow top-line consistently after two years of contraction.

Working capital management deserves close attention, as the cash flow statement for FY25 showed negative ₹2.00 crores from operations despite positive profitability, driven by ₹32.00 crores in adverse working capital changes. Efficient working capital management will be crucial for converting accounting profits into actual cash generation. Additionally, any signs of institutional investor interest—even modest mutual fund or insurance company stakes—would provide validation of the turnaround thesis and potentially improve stock liquidity.